Stocks TSNDF Financial statements
Financial statementsTerrAscend Corp. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data TerrAscend Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 139 | 201 | 249 | 251 | 268 | 261 |
| Cost of revenue | 46.5 | 81.7 | 146 | 112 | 132 | 124 |
| Gross profit | 85.7 | 113 | 102 | 138 | 136 | 136 |
| Research and development | 0.14 | |||||
| Selling, general and administrative | 60.8 | 75.1 | 116 | 115 | ||
| Selling and marketing | 1.67 | 1.86 | 10.3 | 9.66 | ||
| General and administrative | 60.8 | 75.1 | 116 | 83.5 | 90.6 | 86.2 |
| Operating expenses | 65.1 | 89.6 | 437 | 108 | 96.9 | 94.3 |
| Operating income | 20.6 | 22.9 | -336 | 29.7 | 38.9 | 42 |
| Interest expense | 1.96 | 21.2 | 26.8 | 31.1 | 27.5 | 28.8 |
| Other non-operating income | -0.39 | 0.23 | 0.21 | -0.8 | 0.85 | 0.89 |
| Pre-tax income | -117 | 44.5 | -310 | -4.24 | 4.24 | 4.98 |
| Income tax | 10.8 | 28.9 | -10.8 | 23.4 | 25.1 | 29.5 |
| Income from continuing operations | -139 | 12.6 | -304 | -36.4 | -28.5 | -29.4 |
| Net income to minority interests | 3.02 | 4.56 | 8.82 | 7.56 | 4.9 | |
| Net income | -142 | 6.14 | -325 | -86.7 | -72.7 | -81.3 |
| EBITDA | 24.4 | 28.4 | -326 | 35.5 | 44 | 47.4 |
| EPS, basic | -1.03 | 0.02 | -1.35 | -0.34 | -0.28 | -0.29 |
| EPS, diluted | -1.03 | 0.01 | -1.35 | -0.34 | -0.28 | -0.29 |
| Shares, basic (weighted) | 150 | 181 | 244 | 279 | 292 | 301 |
| Shares, diluted (weighted) | 150 | 209 | 244 | 279 | 292 | 301 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 79.6 | 26.2 | 22.2 | 26.4 | 37.4 | |
| Short-term investments | 3.6 | 1.91 | 1.73 | 0.36 | ||
| Receivables | 12.5 | 22.4 | 19 | 20.2 | 16.9 | |
| Inventory | 36.1 | 46.3 | 51.7 | 39.7 | 34.1 | |
| Other current assets | 5.03 | 5.51 | 4.9 | 5.12 | 8.56 | |
| Total current assets | 172 | 122 | 103 | 177 | 110 | |
| Property, plant and equipment | 112 | 216 | 196 | 124 | 130 | |
| Lease right-of-use assets | 43.4 | 29.5 | 43.4 | 28.8 | 26.7 | |
| Goodwill | 72.8 | 90.3 | 90.3 | 107 | 107 | 110 |
| Intangible assets | 168 | 240 | 216 | 170 | 167 | |
| Other non-current assets | 3.14 | 3.46 | 0.85 | 0.72 | 13.5 | |
| Total assets | 582 | 702 | 667 | 607 | 557 | |
| Accounts payable | 27.9 | 44.3 | 49.9 | 40.3 | 39.8 | |
| Deferred revenue | 1.07 | 2.94 | 4.15 | 3.58 | 3.99 | |
| Short-term debt | 39 | 126 | ||||
| Total current liabilities | 66.2 | 138 | 207 | 91 | 79.9 | |
| Lease liabilities | 30.6 | 31.5 | 45.4 | 30.7 | 28.6 | |
| Other non-current liabilities | 13.1 | 15.8 | 2.12 | 0.09 | 0.09 | |
| Total liabilities | 353 | 380 | 426 | 430 | 458 | |
| Total debt | 200 | 206 | 205 | 225 | ||
| Paid-in capital | 535 | 935 | 945 | 952 | 960 | |
| Retained earnings | -315 | -618 | -704 | -779 | -865 | |
| Treasury stock | 0 | 0 | 0 | |||
| Other comprehensive income | 2.82 | 2.09 | 1.8 | 3.01 | 1.99 | |
| Minority interests | 3.8 | 5.37 | 2.37 | -1.76 | -0.14 | 1.54 |
| Total equity | -13.3 | 229 | 321 | 241 | 177 | 99 |
| Total liabilities and equity | 582 | 702 | 667 | 607 | 557 | |
| Shares outstanding | 191 | 260 | 288 | 293 | 309 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -142 | 6.14 | -325 | -86.7 | -72.7 | -81.3 |
| Depreciation and amortization | 3.89 | 5.53 | 9.66 | 5.76 | 5.07 | 5.42 |
| Stock-based compensation | 10.5 | 14.9 | 12.2 | 7.71 | 9.71 | 5.01 |
| Deferred income tax | -12 | -1.25 | -35.3 | -10.3 | 1.37 | -0.53 |
| Change in receivables | -4.04 | -3.21 | 2.86 | -8.68 | -5.3 | 1.65 |
| Change in inventory | -8.09 | -18.5 | 0.68 | -4.25 | 1.17 | 5.95 |
| Cash from operations | -37 | -31.8 | -26.1 | 27.5 | 38 | 21.5 |
| Capital expenditures | -43.8 | -39.8 | -39.6 | -4.87 | -6.87 | -8.61 |
| Acquisitions | -29.7 | -7.04 | -0.75 | -4.93 | -0.39 | |
| Cash from investing | -45.9 | -132 | -27.6 | -16.2 | -12.2 | -14.6 |
| Debt issued | 196 | 0.77 | 43.4 | 23.9 | 129 | 78.9 |
| Debt repaid | -48.9 | -4.5 | -42.2 | -42.8 | -137 | -70.5 |
| Stock issued | 0.1 | |||||
| Share buybacks | -0.22 | -0.41 | ||||
| Cash from financing | 133 | 182 | 3.72 | -12.5 | -24.7 | 4.19 |
| Net change in cash | 50.5 | 18 | -50 | -1.25 | 0.99 | 11.1 |
| Free cash flow | -80.8 | -71.7 | -65.8 | 22.6 | 31.1 | 12.9 |
| Interest paid | 1.96 | 21.2 | 26.8 | 23 | 23.8 | 27.9 |
| Income taxes paid | 11.2 | 37.1 | -9.92 | -3.28 | -5.03 | 9.4 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 52.8% | Gross profit / revenue. |
| Operating margin | 16.1% | Operating income / revenue. |
| EBITDA margin | 18.2% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 1.5% | Pre-tax income / revenue. |
| Net margin | -14.0% | Net income / revenue. |
| FCF margin | 7.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 9.8% | Cash from operations / revenue. |
| Effective tax rate | 801.8% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on assets (ROA) | -6.7% | Net income / average total assets. |
| Stock-based pay / revenue | 1.7% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.5% | Capital expenditures / revenue. |
| D&A / revenue | 2.2% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -2.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 1.5% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 13.4% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 0.3% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 10.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 9.7% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 8.0% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 5y | 15.4% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 7.8% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 5y | 14.2% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -43.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -58.5% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | -8.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -7.4% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 3.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 7.2% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 15.0% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.83x | Current assets / current liabilities. |
| Quick ratio | 0.94x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.68x | (Cash + short-term investments) / current liabilities. |
| Debt / assets | 37.9% | Total debt / total assets. |
| Liabilities / assets | 84.8% | Total liabilities / total assets. |
| Net debt | $167.6M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 3.48x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 1.42x | Operating income / interest expense. |
| Working capital | $51.5M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 52.2% | (Goodwill + intangible assets) / total assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.48x | Revenue / average total assets. |
| Fixed asset turnover | 2.13x | Revenue / average property, plant and equipment. |
| Inventory turnover | 3.18x | Cost of revenue / average inventory. |
| Days inventory | 115 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 16.2x | Revenue / average receivables. |
| Days sales outstanding | 23 days | 365 x average receivables / revenue. |
| Days payables | 118 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 20 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 25.1% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.12 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $0.85 | Revenue / diluted weighted shares. |
| FCF per share | $0.06 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.08 | Cash from operations / diluted weighted shares. |
| Cash per share | $0.14 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 2.2% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $188.6M | Share price x shares outstanding. |
| Enterprise value | $356.2M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.71x | Market cap / revenue. |
| P/FCF | 9.77x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 7.32x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.35x | Enterprise value / revenue. |
| EV/EBIT | 8.39x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 7.40x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 18.4x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 10.2% | Free cash flow / market cap. |
| Earnings yield | -19.6% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 0.2% | (Dividends paid + share buybacks) / market cap. |
What was TerrAscend Corp.'s revenue in fiscal 2025?
TerrAscend Corp. reported revenue of $260.6M for fiscal 2025, 2.8% lower than the year before.
Was TerrAscend Corp. profitable in fiscal 2025?
No. It reported a net loss of $81.3M.
How much free cash flow did TerrAscend Corp. generate in fiscal 2025?
Cash from operations of $21.5M minus capital expenditures of $8.6M left free cash flow of $12.9M.